Atlas Trials

ER-Negative PR-Negative HER2-Negative Breast Neoplasms

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch ER-Negative PR-Negative HER2-Negative Breast Neoplasms

RecordFirmDate
A Study of Neoadjuvant Paclitaxel in Combination With Bavituximab in Early- Stage Triple- Negative Breast Cancer (NCT02685306)Peregrine Pharmaceuticals2016-03-01

Track ER-Negative PR-Negative HER2-Negative Breast Neoplasms automatically

Every clearance here is in the API, with alerts when new ones post.